相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hallmarks of Cancer: New Dimensions
Douglas Hanahan
CANCER DISCOVERY (2022)
Advances in Small-Cell Lung Cancer (SCLC) Translational Research
Benjamin J. Drapkin et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2021)
An Epigenetic Mechanism Underlying Chromosome 17p Deletion-Driven Tumorigenesis
Mei Chen et al.
CANCER DISCOVERY (2021)
Small-cell lung cancer
Charles M. Rudin et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Roles of the HOX Proteins in Cancer Invasion and Metastasis
Ana Paco et al.
CANCERS (2021)
KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer
Hunain Alam et al.
CANCER CELL (2020)
Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases
Zheng Hu et al.
NATURE GENETICS (2020)
A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneity
Kathryn L. Simpson et al.
NATURE CANCER (2020)
Molecular principles of metastasis: a hallmark of cancer revisited
Jawad Fares et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer
C. Allison Stewart et al.
NATURE CANCER (2020)
Next-generation characterization of the Cancer Cell Line Encyclopedia
Mahmoud Ghandi et al.
NATURE (2019)
Axon-like protrusions promote small cell lung cancer migration and metastasis
Dian Yang et al.
ELIFE (2019)
Epigenetic drug library screening identified an LSD1 inhibitor to target UTX-deficient cells for differentiation therapy
Baohong Wu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data
Charles M. Rudin et al.
NATURE REVIEWS CANCER (2019)
Epigenetic drivers of tumourigenesis and cancer metastasis
Aniruddha Chatterjee et al.
SEMINARS IN CANCER BIOLOGY (2018)
Structural basis for DNMT3A-mediated de novo DNA methylation
Zhi-Min Zhang et al.
NATURE (2018)
Minimal functional driver gene heterogeneity among untreated metastases
Johannes G. Reiter et al.
SCIENCE (2018)
Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of Origin
Dian Yang et al.
CANCER DISCOVERY (2018)
Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer
Alvin P. Makohon-Moore et al.
NATURE GENETICS (2017)
Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis
Oliver G. McDonald et al.
NATURE GENETICS (2017)
Small-cell lung cancer: what we know, what we need to know and the path forward
Adi F. Gazdar et al.
NATURE REVIEWS CANCER (2017)
Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis
Jae-Seok Roe et al.
CELL (2017)
Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis
Eric E. Gardner et al.
CANCER CELL (2017)
Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility
Sarah K. Denny et al.
CELL (2016)
Organoid culture systems for prostate epithelial and cancer tissue
Jarno Drost et al.
NATURE PROTOCOLS (2016)
Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients
Ekaterina A. Semenova et al.
CELL REPORTS (2016)
Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer
Liyan Jiang et al.
PLOS GENETICS (2016)
A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 inhibitors in SCLC
Helai P. Mohammad et al.
CANCER CELL (2015)
Comprehensive genomic profiles of small cell lung cancer
Julie George et al.
NATURE (2015)
Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation
Allison Mayle et al.
BLOOD (2015)
MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia
Chong Chen et al.
CANCER CELL (2014)
Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
Cassandra L. Hodgkinson et al.
NATURE MEDICINE (2014)
ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers
Alexander Augustyn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition
Chong Chen et al.
GENES & DEVELOPMENT (2013)
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth et al.
NATURE (2013)
Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position
Jason D. Buenrostro et al.
NATURE METHODS (2013)
NeuroD1 regulates survival and migration of neuroendocrine lung carcinomas via signaling molecules TrkB and NCAM
Jihan K. Osborne et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The COMPASS Family of Histone H3K4 Methylases: Mechanisms of Regulation in Development and Disease Pathogenesis
Ali Shilatifard
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 81 (2012)
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Scott Valastyan et al.
CELL (2011)
Deletion of the de novo DNA methyltransferase Dnmt3a promotes lung tumor progression
Qing Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Loss of p130 Accelerates Tumor Development in a Mouse Model for Human Small-Cell Lung Carcinoma
Bethany E. Schaffer et al.
CANCER RESEARCH (2010)
Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation
Da Jia et al.
NATURE (2007)
Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model
R Meuwissen et al.
CANCER CELL (2003)
A molecular signature of metastasis in primary solid tumors
S Ramaswamy et al.
NATURE GENETICS (2003)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
分享论文
